Found: 47
Select item for more details and to access through your institution.
Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 974, doi. 10.1634/theoncologist.2020-0388
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1819, doi. 10.1002/onco.13538
- By:
- Publication type:
- Article
The Corruption of Science.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 907, doi. 10.1002/onco.13549
- By:
- Publication type:
- Article
Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1803, doi. 10.1002/onco.13532
- By:
- Publication type:
- Article
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET‐Amplified Esophagogastric Cancers.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1691, doi. 10.1634/theoncologist.2020-0274
- By:
- Publication type:
- Article
Professional Medical Writer Assistance in Oncology Clinical Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1812, doi. 10.1634/theoncologist.2020-0406
- By:
- Publication type:
- Article
Long‐Term Response to Intermittent Binimetinib in Patients with NRAS‐Mutant Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1593, doi. 10.1634/theoncologist.2019-0656
- By:
- Publication type:
- Article
A Novel Predictive Model for Idiopathic Multicentric Castleman Disease: The International Castleman Disease Consortium Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 963, doi. 10.1634/theoncologist.2019-0986
- By:
- Publication type:
- Article
Supportive Strategies for Breaking Bad News via Telemedicine.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1816, doi. 10.1634/theoncologist.2020-0526
- By:
- Publication type:
- Article
ASCO 2020: The Geriatric Assessment Comes of Age.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 909, doi. 10.1634/theoncologist.2020-0804
- By:
- Publication type:
- Article
Defining a Distinct Immunotherapy Eligible Subset of Patients with Cancer of Unknown Primary Using Gene Expression Profiling with the 92‐Gene Assay.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1807, doi. 10.1634/theoncologist.2020-0234
- By:
- Publication type:
- Article
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 981, doi. 10.1634/theoncologist.2020-0193
- By:
- Publication type:
- Article
FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1701, doi. 10.1634/theoncologist.2020-0577
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1817, doi. 10.1634/theoncologist.2020-0627
- By:
- Publication type:
- Article
Biomarkers in Breast Cancer: An Integrated Analysis of Comprehensive Genomic Profiling and PD‐L1 Immunohistochemistry Biomarkers in 312 Patients with Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 943, doi. 10.1634/theoncologist.2020-0449
- By:
- Publication type:
- Article
Cladribine with Granulocyte Colony‐Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1663, doi. 10.1634/theoncologist.2020-0818
- By:
- Publication type:
- Article
Tepotinib Efficacy in a Patient with Non‐Small Cell Lung Cancer with Brain Metastasis Harboring an HLA‐DRB1‐MET Gene Fusion.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 916, doi. 10.1634/theoncologist.2020-0502
- By:
- Publication type:
- Article
Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474
- By:
- Publication type:
- Article
Role of Surgery and Perioperative Therapy in Older Patients with Resectable Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1681, doi. 10.1634/theoncologist.2020-0086
- By:
- Publication type:
- Article
Pegaspargase Combined with Concurrent Radiotherapy for Early‐Stage Extranodal Natural Killer/T‐Cell Lymphoma, Nasal Type: A Two‐Center Phase II Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1725, doi. 10.1634/theoncologist.2020-0144
- By:
- Publication type:
- Article
The Impact of Palliative Care Dose Intensity on Outcomes for Patients with Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 913, doi. 10.1634/theoncologist.2020-0551
- By:
- Publication type:
- Article
Value of Precision Medicine in Advanced Non‐Small Cell Lung Cancer: Real‐World Outcomes Associated with the Use of Companion Diagnostics.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1743, doi. 10.1634/theoncologist.2019-0864
- By:
- Publication type:
- Article
Fibroblast Growth Factor Receptor (FGFR) Inhibitors in Urothelial Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1711, doi. 10.1634/theoncologist.2020-0334
- By:
- Publication type:
- Article
Pretreatment Blood Parameters Predict Efficacy from Immunotherapy Agents in Early Phase Clinical Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1732, doi. 10.1634/theoncologist.2020-0518
- By:
- Publication type:
- Article
Organ Dysfunction in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1753, doi. 10.1634/theoncologist.2020-0055
- By:
- Publication type:
- Article
Regarding "HER2 Overexpression as a Poor Prognostic Determinant in Resected Biliary Tract Cancer".
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Phase I Study of Alternate‐Day Administration of S‐1, Oral Leucovorin, and Bevacizumab for Refractory Metastatic Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1614, doi. 10.1634/theoncologist.2020-0463
- By:
- Publication type:
- Article
A Multidisciplinary Approach for Patients with Preexisting Lung Diseases and Immune Checkpoint Inhibitor Toxicities.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1589, doi. 10.1634/theoncologist.2020-0266
- By:
- Publication type:
- Article
Genomic Alterations of NTRK, POLE, ERBB2, and Microsatellite Instability Status in Chinese Patients with Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1671, doi. 10.1634/theoncologist.2020-0356
- By:
- Publication type:
- Article
Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1763, doi. 10.1634/theoncologist.2020-0258
- By:
- Publication type:
- Article
The Art of Oncology: COVID‐19 Era.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 997, doi. 10.1634/theoncologist.2020-0512
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Placebo‐Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment‐Refractory Liposarcoma: Results from the SARC024 Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1655, doi. 10.1634/theoncologist.2020-0679
- By:
- Publication type:
- Article
Successful Treatment of Patients with Refractory High‐Grade Serous Ovarian Cancer with GOPC‐ROS1 Fusion Using Crizotinib: A Case Report.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1720, doi. 10.1634/theoncologist.2019-0609
- By:
- Publication type:
- Article
A Mindfulness‐Based Intervention as a Supportive Care Strategy for Patients with Metastatic Non‐Small Cell Lung Cancer and Their Spouses: Results of a Three‐Arm Pilot Randomized Controlled Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1794, doi. 10.1634/theoncologist.2020-0125
- By:
- Publication type:
- Article
Systemic Steroid Treatment for Imatinib‐Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1785, doi. 10.1634/theoncologist.2019-0953
- By:
- Publication type:
- Article
Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1621, doi. 10.1634/theoncologist.2020-0494
- By:
- Publication type:
- Article
Real‐World Patterns of Everolimus Use in Patients with Metastatic Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 937, doi. 10.1634/theoncologist.2019-0602
- By:
- Publication type:
- Article
An Open‐Label Single‐Arm Phase II Study of Treatment with Neoadjuvant S‐1 Plus Cisplatin for Clinical Stage III Squamous Cell Carcinoma of the Esophagus.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1650, doi. 10.1634/theoncologist.2020-0546
- By:
- Publication type:
- Article
The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1777, doi. 10.1634/theoncologist.2020-0352
- By:
- Publication type:
- Article
Cases from the Immune‐Related Adverse Event Tumor Board: Diagnosis and Management of Immune Checkpoint Blockade‐Induced Diabetes.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 921, doi. 10.1634/theoncologist.2019-0806
- By:
- Publication type:
- Article
Apatinib plus Chemotherapy as a Second‐Line Treatment in Unresectable Non‐Small Cell Lung Carcinoma: A Randomized, Controlled, Multicenter Clinical Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1640, doi. 10.1634/theoncologist.2020-0519
- By:
- Publication type:
- Article
Navigating Roadblocks as an Early Career Attending ... Literally.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 995, doi. 10.1634/theoncologist.2020-0403
- By:
- Publication type:
- Article
A Multicenter Randomized Three‐Arm Phase II Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) with Leuprolide + Letrozole, and (3) Everolimus + EDT in Patients with Unresectable Fibrolamellar Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 925, doi. 10.1634/theoncologist.2020-0367
- By:
- Publication type:
- Article
Phase I Study of Ramucirumab Plus Merestinib in Previously Treated Metastatic Colorectal Cancer: Safety, Preliminary Efficacy, and Pharmacokinetic Findings.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1628, doi. 10.1634/theoncologist.2020-0520
- By:
- Publication type:
- Article
Do I Know You?
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 993, doi. 10.1634/theoncologist.2020-0117
- By:
- Publication type:
- Article
A Phase Ib Study of Single‐Agent Idelalisib Followed by Idelalisib in Combination with Chemotherapy in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1604, doi. 10.1634/theoncologist.2020-0321
- By:
- Publication type:
- Article
The Predictive Value of Early Changes in <sup>18</sup>F‐Fluoroestradiol Positron Emission Tomography/Computed Tomography During Fulvestrant 500 mg Therapy in Patients with Estrogen Receptor‐Positive Metastatic Breast Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 927, doi. 10.1634/theoncologist.2019-0561
- By:
- Publication type:
- Article